Anjay Rastogi, MD in Los Angeles, CA - Medicare Nephrology

Anjay Rastogi, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Los Angeles, California. He graduated from medical school in 1993 and has 31 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice The Regents Of The University Of California and his current practice location is 200 Medical Plaza, #365,420,120,530, Los Angeles, California. You can reach out to his office (for appointments etc.) via phone at (310) 794-9718.

Anjay Rastogi is licensed to practice in California (license number A82681) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003836602.

Contact Information

	Anjay Rastogi, MD
	200 Medical Plaza, #365,420,120,530, Los Angeles, CA 90095-0001
	(310) 794-9718
	Not Available

Physician's Profile

Full Name	Anjay Rastogi
Gender	Male
Speciality	Nephrology
Experience	31 Years
Location	200 Medical Plaza, Los Angeles, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Anjay Rastogi graduated from medical school in 1993

NPI Data:

NPI Number: 1003836602
Provider Enumeration Date: 07/19/2006
Last Update Date: 07/15/2008

Medicare PECOS Information:

PECOS PAC ID: 2163454414
Enrollment ID: I20050907000832

Medical Identifiers

Medical identifiers for Anjay Rastogi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003836602	NPI	-	NPPES
00A826810	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RN0300X	Internal Medicine - Nephrology	A82681 (California)	Primary
207R00000X	Internal Medicine	A82681 (California)	Secondary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Davita-century City Dialysis Center	Los angeles, CA	Dialysis facility
Ronald Reagan Ucla Medical Center	Los angeles, CA	Hospital
Santa Monica - Ucla Med Ctr & Orthopaedic Hospital	Santa monica, CA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
The Regents Of The University Of California	1355248584	1177

News Archive

Censoring 'dual-use' scientific research not an effective strategy to mitigate security risks

"It's easy to get the impression that recent controversy over research into mutated versions of the H5N1 flu virus has created a clear split between a scientific community that wants the research to proceed and the results to be published and a biosecurity community that doesn't," biological-weapons expert Tim Trevan writes in this Nature opinion piece.

Avon Foundation for Women supports innovative research on aggressive breast cancer

The Avon Foundation for Women has awarded a $300,000 grant to Dolores Di Vizio, MD, PhD, associate professor in the Department of Surgery and the Department of Pathology and Laboratory Medicine and a member of the Cancer Biology and Urologic Oncology Research Programs at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute to advance scientific research in aggressive breast cancer.

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).

Research on bacterial cells may offer new hope for MRSA infection treatment

Selfish bacterial cells that act in their own interests and do not cooperate with their infection-causing colleagues can actually reduce the severity of infection.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Anjay Rastogi allows following entities to bill medicare on his behalf.

Entity Name	The Regents Of The University Of California
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1235107566 PECOS PAC ID: 1355248584 Enrollment ID: O20031223000439

News Archive

Censoring 'dual-use' scientific research not an effective strategy to mitigate security risks

Avon Foundation for Women supports innovative research on aggressive breast cancer

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Research on bacterial cells may offer new hope for MRSA infection treatment

Selfish bacterial cells that act in their own interests and do not cooperate with their infection-causing colleagues can actually reduce the severity of infection.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anjay Rastogi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Anjay Rastogi, MD 5767 W Century Blvd, Suite 400, Los Angeles, CA 90045-5632 Ph: (310) 301-8708	Anjay Rastogi, MD 200 Medical Plaza, #365,420,120,530, Los Angeles, CA 90095-0001 Ph: (310) 794-9718

News Archive

Censoring 'dual-use' scientific research not an effective strategy to mitigate security risks

Avon Foundation for Women supports innovative research on aggressive breast cancer

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Research on bacterial cells may offer new hope for MRSA infection treatment

Selfish bacterial cells that act in their own interests and do not cooperate with their infection-causing colleagues can actually reduce the severity of infection.

Internal Medicine Doctors in Los Angeles, CA

Dr. Linda Fong, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-3290
Dr. Robert Peter Gale, Nephrology Medicare: Medicare Enrolled Practice Location: 11693 San Vicente Blvd, Suite 335, Los Angeles, CA 90049 Phone: 310-442-9010
Dr. Tarek Alasil, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8616 La Tijera Blvd Ste 404, Los Angeles, CA 90045 Phone: 310-673-2020 Fax: 310-469-5290
David Michael Tellalian, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8635 W 3rd St Ste 465w, Los Angeles, CA 90048 Phone: 310-358-2300 Fax: 310-358-2308
Dr. Jan B King, M.D., M.P.H. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 11833 Wilmington Ave Fl 2, Los Angeles, CA 90059 Phone: 323-568-8701
Dr. Caroline Hwang, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033 Phone: 323-442-5100
Dr. Jennifer A Fulcher, M.D., PH.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 10833 Le Conte Ave, Chs 37-121, Los Angeles, CA 90095 Phone: 310-825-7225

Anjay Rastogi, MD - Medicare Nephrology in Los Angeles, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Censoring 'dual-use' scientific research not an effective strategy to mitigate security risks

Avon Foundation for Women supports innovative research on aggressive breast cancer

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Research on bacterial cells may offer new hope for MRSA infection treatment

Medicare Reassignments

Censoring 'dual-use' scientific research not an effective strategy to mitigate security risks

Avon Foundation for Women supports innovative research on aggressive breast cancer

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Research on bacterial cells may offer new hope for MRSA infection treatment

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Censoring 'dual-use' scientific research not an effective strategy to mitigate security risks

Avon Foundation for Women supports innovative research on aggressive breast cancer

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Research on bacterial cells may offer new hope for MRSA infection treatment

Internal Medicine Doctors in Los Angeles, CA